BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2021 10:33:58 AM | Browse: 620 | Download: 1369
 |
Received |
|
2021-03-22 09:24 |
|
Peer-Review Started |
|
2021-03-22 09:25 |
|
First Decision by Editorial Office Director |
|
2021-06-14 03:24 |
|
Return for Revision |
|
2021-06-14 03:24 |
|
Revised |
|
2021-06-27 22:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-30 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-30 08:54 |
|
Articles in Press |
|
2021-08-30 08:54 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-10 09:29 |
|
Publish the Manuscript Online |
|
2021-09-15 10:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Minireviews |
| Article Title |
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Michael D Diamantidis, Maria Papaioannou and Evdoxia Hatjiharissi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Evdoxia Hatjiharissi, MD, PhD, N/A, N/A, Division of Hematology, First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, St. Kiriakidis 1, Thessaloniki 54636, Greece. ehatjiharissi@gmail.com |
| Key Words |
Primary gastric lymphoma; Extranodal non-Hodgkin’s lymphoma; Diffuse large B-cell lymphoma; Mucosa-associated lymphoid tissue; Immunochemotherapy; Rituximab-cyclophosphamide doxorubicin vincristine prednisone |
| Core Tip |
A few small, heterogeneous, retrospective studies have attempted to determine the optimal treatment for gastric diffuse large B-cell lymphoma, investigating the role of chemotherapy +/- rituximab, surgery and radiation in patient outcomes. Our retrospective research suggests that a better outcome is observed for these patients after the introduction of immunochemotherapy (rituximab-cyclophosphamide doxorubicin vincristine prednisone). Because statistical analysis might differ among various studies, it is crucial to correctly define the terms freedom from progression and lymphoma-specific survival. The latter provides information on whether the patients died from lymphoma or from other causes. |
| Publish Date |
2021-09-15 10:33 |
| Citation |
Diamantidis MD, Papaioannou M, Hatjiharissi E. Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment . World J Gastroenterol 2021; 27(35): 5932-5945
|
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i35/5932.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i35.5932 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
